[1]
|
Wei YH, Xu LZ, Shen Q, et al. Microdialysis: a technique for pharmacokinetic-pharmacodynamic studies of oncological drugs. Curr Pharm Biotechnol, 2009, 10(6): 631-640. doi: 10.2174/138920109789069288 |
[2]
|
Guihen E, O'Connor WT. Current separation and detection methods in microdialysis the drive towards sensitivity and speed. Electrophoresis, 2009, 30(12): 2062-2075. doi: 10.1002/elps.200900039 |
[3]
|
Muijs CT, Beukema JC, Pruim J, et al. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol, 2010, 97(2): 165-171. doi: 10.1016/j.radonc.2010.04.024 |
[4]
|
Yang Y, Hong H, Zhang Y, et al. Molecular Imaging of Proteases in Cancer. Cancer Growth Metastasis. 2009, 2: 13-27. |
[5]
|
BrunnerM, LangerO. Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J, 2006, 8(2): E263-E271. doi: 10.1007/BF02854896 |
[6]
|
Kalant H. Amicrodialysis procedure for extraction and isolation of corticosteroids from peripheral blood plasma. Biochem J, 1958, 69(1): 99-103. doi: 10.1042/bj0690099 |
[7]
|
Cheng GW, Hsu KC, Lee CF, et al. On-line microdialysis coupled with liquid chromatography for biomedical analysis. J Chromatogr Sci, 2009, 47(8): 624-630. doi: 10.1093/chromsci/47.8.624 |
[8]
|
Hutchinson PJ, O'Connell MT, Seal A, et al. A combined microdialysis and FDG-PET study of glucose metabolism in head injury. Acta Neurochir(Wien), 2009, 151(1): 51-61. doi: 10.1007/s00701-008-0169-1 |
[9]
|
Sarrafzadeh A, Haux D, Plotkin M, et al. Bedside microdialysis reflects dysfunction of cerebral energy metabolism in patients with aneurysmal subarachnoid hemorrhage as confirmed by O-15-H2O-PET and 18F-FDG-PET. J Neuroradiol, 2005, 32(5): 348-351. |
[10]
|
Noske DP, Peerdeman SM, Comans EF, et al. Cerebral microdialysis and positron emission tomography after surgery for aneurysmal subarachnoid hemorrhage in grade Ⅰ patients. Surg Neurol, 2005, 64(2): 109-115. doi: 10.1016/j.surneu.2004.09.036 |
[11]
|
Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Neuroscientist, 2009, 15(6): 635-650. doi: 10.1177/1073858409338217 |
[12]
|
Brooks DJ. Imaging approaches to Parkinson disease. JNuclMed. 2010, 51(4): 596-609. doi: 10.1177/1073858409338217 |
[13]
|
Dohmen C, Bosche B, Graf R, et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke, 2003, 34(9): 2152-2158. doi: 10.1161/01.STR.0000083624.74929.32 |
[14]
|
Hutchinson PJ, Gupta AK, Fryer TF, et al. Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: A combined microdialysis and triple oxygen positron emission tomography study. J Cereb Blood Flow Metab, 2002, 22(6): 735-745. doi: 10.1097/00004647-200206000-00012 |
[15]
|
Schiffer WK, Mirrione MM, Biegon A, et al. Serial micro PET measures of the metabolic reaction to a microdialysis probe implant. J Neurosci Methods, 2006, 155(2): 272-284. |
[16]
|
Yamamoto S, Onoe H, Tsukada H, et al. Effects of increased endogenous serotonin on the in vivo binding of [11C] DASB to serotonin transporters in conscious monkey brain. Synapse, 2007, 61(9): 724-731. doi: 10.1002/syn.20422 |
[17]
|
Virtanen KA, Peltoniemi P, Marjamäki P, et al. Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose[18F] FDG and PET in combination with microdialysis. Diabetologia, 2001, 44(12): 2171-2179. doi: 10.1007/s001250100026 |
[18]
|
Virtanen KA, Haaparanta M, Gronroos T, et al. 2-[18F] fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats. Diabetes Obes Metab, 2002, 4(1): 60-68. |
[19]
|
Houston GC, Hume SP, Hirani E, et al. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C] raclopride in anaesthetised rodents. Synapse, 2004, 51(3): 206-212. doi: 10.1002/syn.10296 |
[20]
|
Doudet DJ, Holden TE. Sequential versus nonsequential measurement of density and affinity of dopamine D(2)receptors with [11C] raclopride: Effect of methamphetamine. J Cereb Blood Flow Metab, 2003, 23(12): 1489-1494. doi: 10.1097/01.WCB.0000093325.88757.92 |
[21]
|
Schiffer WK, Volkow ND, Fowler JS, et al. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse, 2006, 59(4): 243-251. doi: 10.1002/syn.20235 |
[22]
|
Tsukada H, Harada N, Ohba H, et al. Facilitation of dopaminergic neural transmission does not affect [11C] SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-Ⅳ activity through D(1) receptors: PET studies in the conscious monkey brain. Synapse, 2001, 42(4): 258-265. doi: 10.1002/syn.10013 |
[23]
|
Tsukada H, Nishiyama S, Kakiuchi T, et al. Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of (11C) raclopride?: PET studies combined with microdialysis in conscious monkeys. Brain Res, 1999, 841(1-2): 160-169. doi: 10.1016/S0006-8993(99)01834-X |
[24]
|
Hume S, HiraniE, Opacka-Juffry J, et al. Effect of 5-HT on binding of [11C] WAY 100635 to 5-HT(IA)receptors in ratbrain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse, 2001, 41(2): 150-159. doi: 10.1002/syn.1069 |
[25]
|
Peletier L A, Gabrielsson J. Dynamics of target-mediated drug disposition. Eur JPharm Sci, 2009, 38(5): 445-464. doi: 10.1016/j.ejps.2009.09.007 |
[26]
|
Haaparanta M, Grönroos T, MarjamäkiP, et al. In vivo sampling for pharmacokinetic studies in small experimental animals: A combination of microdialysis, planar chromatography and digital autoradiography. Mol Imaging Biol, 2004, 6(1): 27-33. doi: 10.1016/j.mibio.2003.12.005 |
[27]
|
Nakao R, Okada M, Inoue O, et al. Combining high-performance liquid chromatography-positron detection and on-line microdialysis for animal metabolism study of positron emission tomography probes. JChromatogr A, 2008, 1203(2): 193-197. doi: 10.1016/j.chroma.2008.07.049 |
[28]
|
Lindner KJ, Hartvig P, Tedroff J, et al. Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C] DOPA and its metabolites for the validation of positron emission tomography studies. J Pharm Biomed Anal, 1995, 13(4-5): 361-367. doi: 10.1016/0731-7085(95)01291-R |
[29]
|
Langer O, Karch R, Müller U, et al. Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med, 2005, 46(11): 1835-1841. |